XML 63 R23.htm IDEA: XBRL DOCUMENT v3.19.3
Basis of Presentation (Tables)
9 Months Ended
Sep. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Concentration of Net Operating Revenues by Payor
Our Net operating revenues disaggregated by payor source and segment are as follows (in millions):
 
Inpatient Rehabilitation
 
Home Health and Hospice
 
Consolidated
 
Three Months Ended September 30,
 
Three Months Ended September 30,
 
Three Months Ended September 30,
 
2019
 
2018
 
2019
 
2018
 
2019
 
2018
Medicare
$
624.5

 
$
600.5

 
$
248.4

 
$
205.7

 
$
872.9

 
$
806.2

Medicare Advantage
94.7

 
75.0

 
25.2

 
22.7

 
119.9

 
97.7

Managed care
87.3

 
85.1

 
10.4

 
8.6

 
97.7

 
93.7

Medicaid
28.0

 
25.7

 
4.8

 
4.1

 
32.8

 
29.8

Other third-party payors
12.1

 
11.8

 

 

 
12.1

 
11.8

Workers’ compensation
6.9

 
6.9

 
0.3

 
0.5

 
7.2

 
7.4

Patients
6.1

 
5.3

 

 
0.1

 
6.1

 
5.4

Other income
12.7

 
15.3

 
0.2

 
0.3

 
12.9

 
15.6

Total
$
872.3

 
$
825.6

 
$
289.3

 
$
242.0

 
$
1,161.6

 
$
1,067.6


 
Inpatient Rehabilitation
 
Home Health and Hospice
 
Consolidated
 
Nine Months Ended September 30,
 
Nine Months Ended September 30,
 
Nine Months Ended September 30,
 
2019
 
2018
 
2019
 
2018
 
2019
 
2018
Medicare
$
1,892.8

 
$
1,832.1

 
$
684.4

 
$
581.8

 
$
2,577.2

 
$
2,413.9

Medicare Advantage
276.2

 
226.2

 
77.4

 
64.5

 
353.6

 
290.7

Managed care
257.5

 
256.7

 
26.7

 
24.9

 
284.2

 
281.6

Medicaid
81.4

 
77.2

 
13.8

 
7.3

 
95.2

 
84.5

Other third-party payors
32.6

 
36.5

 

 

 
32.6

 
36.5

Workers’ compensation
21.6

 
21.1

 
0.7

 
0.8

 
22.3

 
21.9

Patients
17.8

 
14.1

 
0.5

 
0.8

 
18.3

 
14.9

Other income
36.4

 
36.6

 
0.8

 
0.7

 
37.2

 
37.3

Total
$
2,616.3

 
$
2,500.5

 
$
804.3

 
$
680.8

 
$
3,420.6

 
$
3,181.3


Revision of Previously Issued Financial Statements [Table Text Block] For additional information on this revision, see Note 1, Summary of Significant Accounting Policies, “Revision of Previously Issued Financial Statements” to the consolidated financial statements accompanying the 2018 Form 10-K.
 
For the Nine Months Ended September 30, 2018
 
As Reported
 
Adjustment
 
As Revised
 
(In Millions)
Fair value adjustments to redeemable noncontrolling interests
$
(66.1
)
 
$
(10.9
)
 
$
(77.0
)
Capital in excess of par value
2,673.2

 
(54.9
)
 
2,618.3

Accumulated deficit
(928.1
)
 
14.8

 
(913.3
)
Total shareholders’ equity
1,583.7

 
(40.1
)
 
1,543.6